EPISODE · Jan 28, 2022 · 17 MIN
Trabectedin for recurrent grade 2 or 3 meningiomas
from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Matthias Preusser
Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.
NOW PLAYING
Trabectedin for recurrent grade 2 or 3 meningiomas
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m